Hyaluronic-Acid-Coated Sterosome for Dasatinib Delivery in Hepatocellular Carcinoma: Preparation, Physicochemical Characterization, and In Vitro Evaluation
Biomimetics · 21.08.2025 · 10 (8) · 552
DOI: 10.3390/biomimetics10080552 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomimetics, online erschienen am 21.08.2025. Verfasst von Chae Yeong Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Engineering, Dankook University, Cheonan 31116, Republic of Korea. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Soonchunhyang University, Ministry of Science and ICT, Soonchunhyang University Research Fund.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide, and treatment remains challenging due to high recurrence rates, resistance to chemotherapy, and severe side effects. Dasatinib (Das) has shown therapeutic potential against HCC, but its clinical use is limited by poor bioavailability and short half-life (~3–4 h). Here, we developed a hyaluronic acid (HA)-coated sterosome for targeted and sustained delivery of Das to CD44-overexpressing HCC cells. Sterosomes composed of octadecylamine and cholesterol at a 5:5 (v/v) ratio were prepared via thin-film hydration and sonication, yielding stable particles (~90 nm) with high encapsulation efficiency (EE ~72%) for uncoated vesicles and ~58% after HA coating. HA-sterosomes (HA-St-Das) exhibited a uniform size (≈200 nm) and negative surface charge (–26 mV), with improved storage stability and resistance to lyophilization. In vitro release studies demonstrated pH-responsive Das release accelerated under acidic conditions (pH 6.0–5.0), mimicking tumor and lysosomal environments. In HepG2 cells, HA-St-Das exhibited enhanced cytotoxicity (IC50 ~7.0 μM) and prolonged intracellular retention compared to free Das and uncoated carriers. Fluorescence microscopy confirmed receptor-mediated uptake via CD44, leading to gradual and sustained intracellular delivery. Overall, the HA-St-Das system provides biocompatible, targeted, and controlled Das delivery, addressing key limitations of current liver cancer therapies and representing a promising nanomedicine platform for further development.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Engineering, Dankook University, Cheonan 31116, Republic of Korea.
- Department of Pharmaceutical Engineering, Soonchunhyang University, Asan 31538, Republic of Korea.
ORCID-Profile: Hee Sook Hwang
Förderung
- Soonchunhyang University
- Ministry of Science and ICT
- Soonchunhyang University Research Fund
- Korean government (MSIT)
Zitieren
APA
Lee, C. Y., Lee, J. M., Lee, C. S., & Hwang, H. S. (2025). Hyaluronic-Acid-Coated Sterosome for Dasatinib Delivery in Hepatocellular Carcinoma: Preparation, Physicochemical Characterization, and In Vitro Evaluation. Biomimetics, 10(8), 552. https://doi.org/10.3390/biomimetics10080552
Vancouver
Lee CY, Lee JM, Lee CS, Hwang HS. Hyaluronic-Acid-Coated Sterosome for Dasatinib Delivery in Hepatocellular Carcinoma: Preparation, Physicochemical Characterization, and In Vitro Evaluation. Biomimetics. 2025;10(8):552. doi:10.3390/biomimetics10080552
BibTeX
@article{Lee2025,
author = {Lee, Chae Yeong and Lee, Jeong Min and Lee, Chung-Sung and Hwang, Hee Sook},
title = {Hyaluronic-Acid-Coated Sterosome for Dasatinib Delivery in Hepatocellular Carcinoma: Preparation, Physicochemical Characterization, and In Vitro Evaluation},
journal = {Biomimetics},
year = {2025},
volume = {10},
number = {8},
pages = {552},
doi = {10.3390/biomimetics10080552}
}
EUVIMED